Artikel mit Open-Access-Mandaten - Vangelis ManolopoulosWeitere Informationen
Nicht verfügbar: 6
Genotype-guided versus standard vitamin K antagonist dosing algorithms in patients initiating anticoagulation
EP Belley-Cote, H Hanif, F D’Aragon, JW Eikelboom, JL Anderson, ...
Thrombosis and haemostasis 114 (10), 768-777, 2015
Mandate: UK Medical Research Council, National Institute for Health Research, UK
Vitamin D Receptor ApaI a Allele Is Associated with Better Childhood Asthma Control and Improvement in Ability for Daily Activities
M Iordanidou, E Paraskakis, E Giannakopoulou, A Tavridou, G Gentile, ...
Omics: a journal of integrative biology 18 (11), 673-681, 2014
Mandate: National Institute for Health Research, UK
Influence of CYP3A5 polymorphism on the pharmacokinetics of psychiatric drugs
G Ragia, ML Dahl, V G Manolopoulos
Current Drug Metabolism 17 (3), 227-236, 2016
Mandate: Swedish Research Council
No effect of CYP3A4 intron 6 C> T polymorphism (CYP3A4* 22) on lipid-lowering response to statins in Greek patients with primary hypercholesterolemia
G Ragia, V Kolovou, A Tavridou, L Elens, AD Tselepis, M Elisaf, ...
Drug metabolism and personalized therapy 30 (1), 43-48, 2015
Mandate: National Fund for Scientific Research, Belgium
Lack of association of the p450 oxidoreductase* 28 single nucleotide polymorphism with the lipid-lowering effect of statins in hypercholesterolemic patients
G Ragia, V Kolovou, A Tavridou, L Elens, AD Tselepis, M Elisaf, ...
Molecular Diagnosis & Therapy 18, 323-331, 2014
Mandate: National Fund for Scientific Research, Belgium
The revolution of pharmaco-omics: ready to open new avenues in materializing precision medicine?
G Ragia, VG Manolopoulos
Pharmacogenomics 23 (16), 869-872, 2022
Mandate: US National Institutes of Health
Verfügbar: 13
A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon
TI Verhoef, G Ragia, A de Boer, R Barallon, G Kolovou, V Kolovou, ...
New England Journal of Medicine 369 (24), 2304-2312, 2013
Mandate: Swedish Research Council
A global view of the OCA2-HERC2 region and pigmentation
MP Donnelly, P Paschou, E Grigorenko, D Gurwitz, C Barta, RB Lu, ...
Human genetics 131, 683-696, 2012
Mandate: US National Institutes of Health
Cardioprotection by H2S donors: nitric oxide-dependent and‑independent mechanisms
A Chatzianastasiou, SI Bibli, I Andreadou, P Efentakis, N Kaludercic, ...
Journal of Pharmacology and Experimental Therapeutics 358 (3), 431-440, 2016
Mandate: US National Institutes of Health, UK Medical Research Council, European …
The distribution and most recent common ancestor of the 17q21 inversion in humans
MP Donnelly, P Paschou, E Grigorenko, D Gurwitz, SQ Mehdi, ...
The American Journal of Human Genetics 86 (2), 161-171, 2010
Mandate: US National Institutes of Health
Pharmacogenomics education in medical and pharmacy schools: conclusions of a global survey
N Karas Kuželički, I Prodan Žitnik, D Gurwitz, A Llerena, I Cascorbi, ...
Pharmacogenomics 20 (9), 643-657, 2019
Mandate: European Commission
Quality of life in patients with venous thromboembolism and atrial fibrillation treated with coumarin anticoagulants
CL Marvig, TI Verhoef, A De Boer, F Kamali, K Redekop, M Pirmohamed, ...
Thrombosis Research 136 (1), 69-75, 2015
Mandate: Swedish Research Council, UK Medical Research Council, National Institute …
CYP2C9* 2 allele increases risk for hypoglycemia in POR* 1/* 1 type 2 diabetic patients treated with sulfonylureas
G Ragia, A Tavridou, L Elens, RHN Van Schaik, VG Manolopoulos
Experimental and Clinical Endocrinology & Diabetes 122 (01), 60-63, 2014
Mandate: National Fund for Scientific Research, Belgium
Rationale and design of the multiethnic Pharmacogenomics in Childhood Asthma consortium
N Farzan, SJ Vijverberg, AK Andiappan, L Arianto, V Berce, ...
Pharmacogenomics 18 (10), 931-943, 2017
Mandate: US National Institutes of Health, Swedish Research Council, UK Medical …
Patients benefit from genetics‐guided coumarin anticoagulant therapy
AHM van der Zee, AK Daly, F Kamali, VG Manolopoulous, TI Verhoef, ...
Clinical Pharmacology & Therapeutics 96 (1), 15-17, 2014
Mandate: UK Medical Research Council, National Institute for Health Research, UK
Dosing algorithms for vitamin K antagonists across VKORC1 and CYP2C9 genotypes
EV Baranova, TI Verhoef, G Ragia, S Le Cessie, FW Asselbergs, ...
Journal of Thrombosis and Haemostasis 15 (3), 465-472, 2017
Mandate: Swedish Research Council, UK Medical Research Council, National Institute …
Public health pharmacogenomics and the design principles for global public goods–moving genomics to responsible innovation
V Özdemir, A Borda-Rodriguez, ES Dove, LR Ferguson, F Huzair, ...
Current pharmacogenomics and personalized medicine 11 (1), 1, 2013
Mandate: US National Institutes of Health, Canadian Institutes of Health Research …
Age‐stratified outcome of a genotype‐guided dosing algorithm for acenocoumarol and phenprocoumon
Y Zhang, A de Boer, TI Verhoef, FJM van der Meer, S Le Cessie, ...
Journal of Thrombosis and Haemostasis 15 (3), 454-464, 2017
Mandate: UK Medical Research Council, National Institute for Health Research, UK
The 10th Santorini conference: Systems medicine, personalised health and therapy.“The odyssey from hope to practice: Patient first. Keep Ithaca always in your mind”, Santorini …
S Visvikis-Siest, MG Stathopoulou, R Sunder-Plassmann, BZ Alizadeh, ...
Frontiers in Genetics 14, 1171131, 2023
Mandate: National Institute of Health and Medical Research, France
Angaben zur Publikation und Finanzierung werden automatisch von einem Computerprogramm ermittelt